Brands: Norvasc · Amlodipine Besylate
Average across 104 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 122 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | repackager | 56 | SUPPLYING |
| Proficient Rx LP | repackager | 42 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 32 | SUPPLYING |
| A-S Medication Solutions | repackager | 28 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | repackager | 27 | SUPPLYING |
| NCS HealthCare of KY, LLC dba Vangard Labs | repackager | 23 | SUPPLYING |
| Ascend Laboratories, LLC | generic | 21 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 18 | SUPPLYING |
| Exelan Pharmaceuticals Inc. | unknown | 18 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 17 | SUPPLYING |
| Zydus Lifesciences Limited | generic | 12 | SUPPLYING |
| Cipla USA Inc. | generic | 12 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 12 | SUPPLYING |
| Oxford Pharmaceuticals, LLC | unknown | 12 | SUPPLYING |
+ 27 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed directly to three distributors in TN and NJ. Product may have been further distributed througho…
Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition. — Recalling firm: InvaGen Pharmaceuticals, Inc. — Nationwide with the United States
PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg. — Recalling firm: Ascend Laboratories LLC — Nationwide in the USA.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications. — Recalling firm: Lupin Limited — US No recalled product was distributed to any foreign consignees by Lupin.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications. — Recalling firm: Lupin Limited — US No recalled product was distributed to any foreign consignees by Lupin.
Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344. — Recalling firm: Zydus Pharmaceuticals USA Inc — Nationwide
